Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 89 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Sarafidis, Pantelis A [Clear All Filters]
Ambulatory Blood Pressure Trajectories and Blood Pressure Variability in Diabetic and Non-Diabetic Chronic Kidney Disease..
Am J Nephrol. 51(5), 411-420.
(2020). The association of interdialytic blood pressure variability with cardiovascular events and all-cause mortality in haemodialysis patients..
Nephrol Dial Transplant. 35(7), 1277.
(2020). Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference..
Kidney Int. 97(5), 861-876.
(2020). Chronic Therapy with Sucroferric Oxyhydroxide Does Not Affect Iron and Anemia Markers in Dialysis Patients..
Blood Purif. 49(4), 440-447.
(2020). Excess volume removal following lung ultrasound evaluation decreases central blood pressure and pulse wave velocity in hemodialysis patients: a LUST sub-study..
J Nephrol. 33(6), 1289-1300.
(2020). Heart Failure and Atrial Fibrillation Modify the Associations of Nocturnal Blood Pressure Dipping Pattern With Mortality in Hemodialysis Patients..
Hypertension. 76(4), 1231-1239.
(2020). Hyponatremia accompanying volatile hypertension caused by baroreflex failure after neck surgery: case report and literature review..
J Hypertens. 38(8), 1617-1624.
(2020). In Reply to 'Lung Ultrasound in Hemodialysis Patients: Is it Practical to Scan 28 Zones?'.
Am J Kidney Dis. 75(5), 816.
(2020). The risk for urinary tract infections with sodium-glucose cotransporter 2 inhibitors: no longer a cause of concern?.
Clin Kidney J. 13(1), 24-26.
(2020). Serum Copeptin, NLPR3, and suPAR Levels among Patients with Autosomal-Dominant Polycystic Kidney Disease with and without Impaired Renal Function..
Cardiorenal Med. 1-12.
(2020). Volume overload in hemodialysis: diagnosis, cardiovascular consequences, and management..
Nephrol Dial Transplant.
(2020). The association of interdialytic blood pressure variability with cardiovascular events and all-cause mortality in haemodialysis patients..
Nephrol Dial Transplant. 34(3), 515-523.
(2019). Comparison of 24-hour and Office Pulse Wave Velocity for Prediction of Mortality in Hemodialysis Patients..
Am J Nephrol. 49(4), 317-327.
(2019). The effect of dry-weight reduction guided by lung ultrasound on ambulatory blood pressure in hemodialysis patients: a randomized controlled trial..
Kidney Int. 95(6), 1505-1513.
(2019). The effects of nebivolol and irbesartan on postdialysis and ambulatory blood pressure in patients with intradialytic hypertension: a randomized cross-over study..
J Hypertens. 37(2), 432-442.
(2019). Increased Sclerostin, but Not Dickkopf-1 Protein, Is Associated with Elevated Pulse Wave Velocity in Hemodialysis Subjects..
Kidney Blood Press Res. 44(4), 679-689.
(2019). Lung Ultrasound-Guided Dry-Weight Reduction in Hemodialysis Patients Does Not Affect Short-Term Blood Pressure Variability..
Am J Hypertens. 32(8), 786-795.
(2019). Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTA..
Nephrol Dial Transplant. 34(9), 1542-1548.
(2019). Weak within-individual association of blood pressure and pulse wave velocity in hemodialysis is related to adverse outcomes..
J Hypertens. 37(11), 2200-2208.
(2019). Antihypertensive therapy in acute ischemic stroke: where do we stand?.
J Hum Hypertens. 32(12), 799-807.
(2018). Association of Ambulatory Blood Pressure with All-Cause and Cardiovascular Mortality in Hemodialysis Patients: Effects of Heart Failure and Atrial Fibrillation..
J Am Soc Nephrol. 29(9), 2409-2417.
(2018). Blood pressure variability increases with advancing chronic kidney disease stage: a cross-sectional analysis of 16 546 hypertensive patients..
J Hypertens. 36(5), 1076-1085.
(2018). The Ebb and Flow of Echocardiographic Cardiac Function Parameters in Relationship to Hemodialysis Treatment in Patients with ESRD..
J Am Soc Nephrol. 29(5), 1372-1381.
(2018). Levels of Endocan, Angiopoietin-2, and Hypoxia-Inducible Factor-1a in Patients with Autosomal Dominant Polycystic Kidney Disease and Different Levels of Renal Function..
Am J Nephrol. 47(4), 231-238.
(2018). Mineralocorticoid Receptor Antagonists for Nephroprotection: Current Evidence and Future Perspectives..
Curr Pharm Des. 24(46), 5528-5536.
(2018). Σελίδες
- 1
- 2
- 3
- 4
- επόμενη ›
- τελευταία »